Your browser doesn't support javascript.
loading
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study.
Yang, Jingyan; Andersen, Kathleen Michelle; Rai, Kiran K; Tritton, Theo; Mugwagwa, Tendai; Reimbaeva, Maya; Tsang, Carmen; McGrath, Leah J; Payne, Poppy; Backhouse, Bethany Emma; Mendes, Diana; Butfield, Rebecca; Naicker, Kevin; Araghi, Mary; Wood, Robert; Nguyen, Jennifer L.
Afiliação
  • Yang J; Pfizer Inc, New York, New York, USA jingyan.yang@pfizer.com.
  • Andersen KM; The Institute for Social and Economic Research and Policy, Columbia University, New York, New York, USA.
  • Rai KK; Pfizer Inc, New York, New York, USA.
  • Tritton T; Adelphi Real World, Bollington, UK.
  • Mugwagwa T; Adelphi Real World, Bollington, UK.
  • Reimbaeva M; Pfizer Inc, New York, New York, USA.
  • Tsang C; Pfizer Inc, New York, New York, USA.
  • McGrath LJ; Pfizer, Tadworth, UK.
  • Payne P; Pfizer Inc, New York, New York, USA.
  • Backhouse BE; Adelphi Real World, Bollington, UK.
  • Mendes D; Adelphi Real World, Bollington, UK.
  • Butfield R; Pfizer, Tadworth, UK.
  • Naicker K; Pfizer, Tadworth, UK.
  • Araghi M; Pfizer, Tadworth, UK.
  • Wood R; Pfizer, Tadworth, UK.
  • Nguyen JL; Adelphi Real World, Bollington, UK.
BMJ Open ; 13(12): e075495, 2023 12 28.
Article em En | MEDLINE | ID: mdl-38154885
ABSTRACT

OBJECTIVES:

To quantify direct costs and healthcare resource utilisation (HCRU) associated with acute COVID-19 in adults in England.

DESIGN:

Population-based retrospective cohort study using Clinical Practice Research Datalink Aurum primary care electronic medical records linked to Hospital Episode Statistics secondary care administrative data.

SETTING:

Patients registered to primary care practices in England. POPULATION 1 706 368 adults with a positive SARS-CoV-2 PCR or antigen test from August 2020 to January 2022 were included; 13 105 within the hospitalised cohort indexed between August 2020 and March 2021, and 1 693 263 within the primary care cohort indexed between August 2020 and January 2022. Patients with a COVID-19-related hospitalisation within 84 days of a positive test were included in the hospitalised cohort. MAIN OUTCOME

MEASURES:

Primary and secondary care HCRU and associated costs ≤4 weeks following positive COVID-19 test, stratified by age group, risk of severe COVID-19 and immunocompromised status.

RESULTS:

Among the hospitalised cohort, average length of stay, including critical care stays, was longer in older adults. Median healthcare cost per hospitalisation was higher in those aged 75-84 (£8942) and ≥85 years (£8835) than in those aged <50 years (£7703). While few (6.0%) patients in critical care required mechanical ventilation, its use was higher in older adults (50-74 years 8.3%; <50 years 4.3%). HCRU and associated costs were often greater in those at higher risk of severe COVID-19 than in the overall cohort, although minimal differences in HCRU were found across the three different high-risk definitions. Among the primary care cohort, general practitioner or nurse consultations were more frequent among older adults and the immunocompromised.

CONCLUSIONS:

COVID-19-related hospitalisations in older adults, particularly critical care stays, were the primary drivers of high COVID-19 resource use in England. These findings may inform health policy decisions and resource allocation in the prevention and management of COVID-19.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article